EP3091985

PROSTANGLANDINS FOR TOPICAL USE IN THE TREATMENT OF MIGRAINES.

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    9.1.2015
  • EP published:
    8.5.2024
  • EP application number:
    15735190.9
  • Max expiry date:
    8.1.2035
  • Title in English:
    PROSTANGLANDINS FOR TOPICAL USE IN THE TREATMENT OF MIGRAINES.
  • Language of the patent:
    English

Timeline

Today
9.1.2015EP application
8.5.2024EP Publication

Owner

  • Name:
    Manistee Therapeutics, Inc.
  • Address:
    84 Barnes Hill Road, Concord, MA 01742-5601, US

Inventor

  • Name:
    BRATZLER, Robert, L.
  • Address:
    Concord, MA 01742, US
  • Name:
    WAND, Martin
  • Address:
    Farmington, CT 06032-1803, US
  • Name:
    RYCKMAN, Frederick
  • Address:
    West Chester, OH 45069, US
  • Name:
    SHINGLETON, Bradford, J.
  • Address:
    Boston, MA 02108, US

Priority

  • Number:
    201461925676 P
  • Date:
    10.1.2014
  • Country:
    US

Classification

  • Categories:
    A61K 31/5575, A61K 9/00, A61P 25/06

Upload documents